Contact/News Media

Wednesday, July 31, 2019

Chemists teach old drug new tricks to target deadly staph bacteria

Emory chemist Bill Wuest, far right, with some of his graduate students, from left: Erika Csatary, Madeleine Dekarske and Ingrid Wilt. Photo by Ann Watson.

"Saying superbugs, one antibiotic at a time,” is the motto of Bill Wuest’s chemistry lab at Emory University. Wuest (it rhymes with “beast”) leads a team of students fighting drug-resistant bacteria — some of the scariest, most dangerous bugs on the planet.

Most recently, they created new molecules for a study published in PNAS. Their work helped verify how bithionol — a drug used to treat parasitic infections — can weaken the cell membranes of “persister” cells of methicillin-resistant Staphylococcus aureus (MRSA), a deadly staph bacterium. They also synthesized new compounds, to learn more about how bithionol works and enhance its potential for clinical use.

“Just before I entered graduate school, my mother was diagnosed with a severe staph infection,” says Ingrid Wilt, a PhD candidate, explaining what drives her passion to tackle MRSA.

“She was in a hospital in the ICU for about two weeks,” Wilt adds. “Luckily, a last-resort antibiotic worked for her and she’s okay now.”

Click here to read the full story.

Related:
Chemistry students sing their studies, hoping for a good reaction
Brazilian peppertree packs power to knock out antibiotic-resistant bacteria

No comments:

Post a Comment